Alligator Bioscience
Clinical-stage biotech developing tumor-directed immuno-oncology antibody drugs.
ATORX | ST
Overview
Corporate Details
- ISIN(s):
- SE0000767188 (+8 more)
- LEI:
- 549300E15VI0MB7LXV19
- Country:
- Sweden
- Address:
- C/O Medicon Village, 223 81 Lund
- Sector:
- Manufacturing
Description
Alligator Bioscience is a clinical-stage biotechnology company that develops tumor-directed immuno-oncology antibody drugs. The company's core strategy is to activate the patient's own immune system to fight cancer. It utilizes a proprietary technology platform for the discovery and development of novel antibody-based pharmaceuticals. The development pipeline features several drug candidates, including its lead asset mitazalimab, a CD40 agonist. The company specializes in creating therapeutics that are designed to be effective against various forms of cancer.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2021-08-18 08:00 |
Alligator Bioscience ingår immunonkologiskt forskningssamarbete och licensavtal…
|
Swedish | 161.1 KB | ||
| 2021-08-18 08:00 |
Alligator Bioscience announces Immuno-oncology Research Collaboration and Licen…
|
English | 165.0 KB | ||
| 2021-06-04 08:00 |
Alligator Bioscience presenterar positiva fas I-data på ASCO för 4-1BB-antikrop…
|
Swedish | 158.5 KB | ||
| 2021-06-04 08:00 |
Alligator Bioscience presents positive Phase I data at ASCO for its 4-1BB agoni…
|
English | 162.5 KB | ||
| 2021-06-01 14:30 |
Kommuniké från årsstämma den 1 juni 2021 i Alligator Bioscience AB
|
Swedish | 154.1 KB | ||
| 2021-06-01 14:30 |
Bulletin from the annual general meeting in Alligator Bioscience AB on June 1, …
|
English | 155.1 KB | ||
| 2021-04-30 09:40 |
Styrelseledamot i Alligator Bioscience AB avgår på egen begäran
|
Swedish | 139.7 KB | ||
| 2021-04-30 09:40 |
Board member in Alligator Bioscience resigns at his own request
|
English | 140.9 KB | ||
| 2021-04-27 08:00 | Swedish | 1.4 MB | |||
| 2021-04-27 08:00 | English | 1.4 MB | |||
| 2021-04-26 19:30 |
Kallelse till årsstämma i Alligator Bioscience AB
|
Swedish | 254.5 KB | ||
| 2021-04-26 19:30 |
Notice of annual general meeting in Alligator Bioscience AB
|
English | 270.6 KB | ||
| 2021-04-22 19:30 |
Valberedningens förslag till styrelse inför årsstämman 2021 i Alligator Bioscie…
|
Swedish | 193.1 KB | ||
| 2021-04-22 19:30 |
The Nomination Committee’s proposal regarding the board of directors ahead of t…
|
English | 191.2 KB | ||
| 2021-04-03 11:00 |
Alligator Bioscience flyttar fram årsstämman till 1 juni 2021
|
Swedish | 101.6 KB |
Automate Your Workflow. Get a real-time feed of all Alligator Bioscience filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Alligator Bioscience
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Alligator Bioscience via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| 2025-02-28 | Peter Ostler | Other | Sell | 1,658,134 | 179,045.31 SEK |
| 2024-04-11 | Staffan Encrantz | Other | Sell | 44,108,581 | 47,196,181.67 SEK |
| 2022-10-27 | Sören Bregenholt Frederiksen | Other | Buy | 52,000 | 72,748.00 SEK |
| 2022-10-25 | Marie Svensson | Other | Buy | 12,000 | 16,632.00 SEK |
| 2022-08-19 | Sören Bregenholt Frederiksen | Other | Buy | 13,906 | 25,726.10 SEK |
| 2022-08-18 | Sören Bregenholt Frederiksen | Other | Buy | 31,094 | 56,911.35 SEK |
| 2022-05-31 | Peter Ostler | Other | Buy | 100,000 | 151,500.00 SEK |
| 2022-05-04 | Sören Bregenholt Frederiksen | Other | Buy | 30,000 | 50,895.00 SEK |
| 2022-05-02 | Sören Bregenholt Frederiksen | Other | Buy | 30,000 | 50,811.00 SEK |
| 2022-04-30 | Sören Bregenholt Frederiksen | Other | Buy | 30,000 | 51,171.00 SEK |
Peer Companies
